The probability of recurrence and metastasis of renal cancer

What is the probability of recurrence and metastasis of kidney cancer? Whether in the early or late stages of cancer, recurrence and metastasis are difficult to avoid. Kidney cancer can spread through the primary tumor to adjacent tissues and invade, or it can metastasize outward through lymphatic vessels or veins. The following are common sites of recurrence and metastasis of kidney cancer.

Kidney cancer patients are prone to relapse after surgery. The main reason is that surgical treatment is not thorough, it is easy to leave residual lesions and cannot remove cancer cells scattered in the lymphatic tissue. The remaining cancer cells can easily cause secondary relapse in patients. Not only does it bring a greater economic burden to patients, but more importantly, it will further increase the difficulty of treatment and make patients lose the opportunity for treatment. The recurrence rate of kidney cancer is still very high.
Biological cell therapy for recurrent renal cancer can make up for the deficiencies of surgical treatment, radiotherapy and chemotherapy. Long-term treatment after surgery with biological cell therapy can prevent recurrence and metastasis. Radiotherapy and chemotherapy have considerable side effects on the digestive tract and hematopoietic system. The use of biological cell therapy can not only reduce the side effects of radiotherapy and chemotherapy, but also play a role in increasing efficacy and reducing toxicity.